title: Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene.
authors.affiliation: Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Viale Golgi 19, 27100, Pavia, Italy. elisarumi@hotmail.com.
authors.forename: Elisa
authors.identifier: http://orcid.org/0000-0002-7572-9504
authors.initials: E
authors.lastname: Rumi
authors.affiliation: CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
authors.forename: Jelena D
authors.initials: JD
authors.lastname: Milosevic
authors.affiliation: AZ Sint-Jan, Brugge, Belgium.
authors.forename: Dominik
authors.initials: D
authors.lastname: Selleslag
authors.affiliation: Department of Molecular Medicine, University of Pavia, Pavia, Italy.
authors.forename: Ilaria
authors.initials: I
authors.lastname: Casetti
authors.affiliation: Center for Human Genetics, KU Leuven/University Hospital Leuven, Leuven, Belgium.
authors.forename: Els
authors.initials: E
authors.lastname: Lierman
authors.affiliation: Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Viale Golgi 19, 27100, Pavia, Italy.
authors.forename: Daniela
authors.initials: D
authors.lastname: Pietra
authors.affiliation: Department of Molecular Medicine, University of Pavia, Pavia, Italy.
authors.forename: Chiara
authors.initials: C
authors.lastname: Cavalloni
authors.affiliation: Department of Molecular Medicine, University of Pavia, Pavia, Italy.
authors.forename: Marta
authors.initials: M
authors.lastname: Bellini
authors.affiliation: Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Viale Golgi 19, 27100, Pavia, Italy.
authors.forename: Chiara
authors.initials: C
authors.lastname: Milanesi
authors.affiliation: Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Viale Golgi 19, 27100, Pavia, Italy.
authors.forename: Irene
authors.initials: I
authors.lastname: Dambruoso
authors.affiliation: Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Viale Golgi 19, 27100, Pavia, Italy.
authors.forename: Cesare
authors.initials: C
authors.lastname: Astori
authors.affiliation: CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.|Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria.
authors.forename: Robert
authors.initials: R
authors.lastname: Kralovics
authors.affiliation: Center for Human Genetics, KU Leuven/University Hospital Leuven, Leuven, Belgium.
authors.forename: Peter
authors.initials: P
authors.lastname: Vandenberghe
authors.affiliation: Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Viale Golgi 19, 27100, Pavia, Italy.|Department of Molecular Medicine, University of Pavia, Pavia, Italy.
authors.forename: Mario
authors.initials: M
authors.lastname: Cazzola
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000188:drug therapy* / Q000235:genetics; D007938:Leukemia; D008297:Male; D009196:Myeloproliferative Disorders / Q000188:drug therapy* / Q000235:genetics; D009570:Nitriles; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines; D012074:Remission Induction; D016896:Treatment Outcome
chemical_list: D009570:Nitriles; D015514:Oncogene Proteins, Fusion; C575876:PCM1-JAK2 fusion protein, human; D011720:Pyrazoles; D011743:Pyrimidines; C540383:ruxolitinib